$512M Settlement Reached in Cephalon Reverse-Payment Case

An antitrust lawsuit against Cephalon and associated pharmaceutical companies involving the alleged delay of introducing a generic version of the drug Provigil into the market has settled for $512 million.

Online Only

Pa. Law Weekly

read more

Special Reports

  • Intellectual Property

    The Intellectual Property supplement includes articles on fashion design, the Kessler doctrine, the U.S. Supreme Court shifting power back to the district courts and more.

  • Corporate Governance

    The Corporate Governance supplement includes articles on managing the threat of a derivative lawsuit, succession planning for a board of directors, approaches to risk management, corporate governance in the nonprofit sector and more.

read more

All Columns

read more

Courts and Cases

read more

Twitter Feed

Video Center

Corporate Counsel Breakfast

The Legal Intelligencer
Leading attorneys from corporations throughout the Delaware Valley gathered for the Legal's annual corporate counsel breakfast.
read more